GMPS forms a bridge between nascent PD-L1 and the oligo-saccharyl-transferase catalytic sub-unit STT3A; this STT3A-dependent glycosylation stabilizes PD-L1 and impairs the tumor-killing function of CD8+ T cells [30]. This evidence concerns the gene CD8A and neoplasm.